ACE2 and Hypertension: Substantial data supports that RAS and ACE inhibitors and angiotensin-receptor blockers (ARBs), which are frequently used in patients with hypertension and CVD and to a lesser extent diabetes, induce increased expression of ACE2 as recently reviewed (Chung et al., 2020).